$NASDAQ:EXAS

Exact Sciences Reports Positive Developments, But Remains Unprofitable and Mediocre Guidance for 2023.

Trending News ☀️ Overall, Exact Sciences ($NASDAQ:EXAS) reported some positive developments in their Q4 results, but the company is still [...]

By |March 6, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments

EXACT SCIENCES Reports 42.1% Revenue Increase and 16.7% Increase in Net Income for FY2022 Q4

Earnings report On December 31 2022, EXACT SCIENCES ($NASDAQ:EXAS) reported their earnings results for FY2022 Q4 ending February 21 2023. [...]

Exact Sciences Corporation Reaps Rewards of Windfall in 2023, Stock Up Over a Third Since Start of Year

Trending News ☀️ Exact Sciences ($NASDAQ:EXAS) Corporation, a cancer screening and diagnostic firm, saw a major jump in their stocks [...]

By |February 20, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments

Exact Sciences Intrinsic Value – Exact Sciences Corporation Shares Show Potential for Correction Following 2.13% Increase to $68.57.

Trending News ☀️ Exact Sciences Intrinsic Value - Exact Sciences ($NASDAQ:EXAS) Corporation is a publicly traded biotechnology company that specializes [...]

By |February 13, 2023|Categories: Diagnostics & Research, Intrinsic Value|Tags: , , |0 Comments

Exact Sciences Intrinsic Stock Value – Creative Planning Increases Investment in Exact Sciences Co. by $927000.

Trending News ☀️ Exact Sciences Intrinsic Stock Value - Exact Sciences ($NASDAQ:EXAS) Co. is a publicly traded biotechnology company based [...]

By |February 1, 2023|Categories: Diagnostics & Research, Intrinsic Value|Tags: , , |0 Comments

Cathie Wood Profits from Selling Over 100K Shares of Exact Sciences as Stock Rises 35%

Trending News ☀️ Exact Sciences ($NASDAQ:EXAS) is a publicly-traded healthcare company that focuses on cancer and other diseases. The company [...]

By |January 31, 2023|Categories: Diagnostics & Research, Profitability|Tags: , , |0 Comments

Exact Sciences Expects 28% Year-Over-Year Increase in Q4 Revenue, Between $5M – $143.5M

Trending News ☀️ Exact Sciences ($NASDAQ:EXAS) is a molecular diagnostics company that provides products and services to healthcare providers and [...]

By |January 10, 2023|Categories: Diagnostics & Research, Profitability|Tags: , , |0 Comments
Go to Top